Bluelinea SA
PAR:ALBLU
Bluelinea SA
PAR:ALBLU
Price:
0.492
EUR
Market Cap:
€9.1m
Relative Value
The Relative Value of one
ALBLU
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 0.492 EUR,
Bluelinea SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALBLU Relative Value
HIDDEN
Multiples Across Competitors
ALBLU Competitors Multiples
Bluelinea SA Competitors
Bluelinea SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Bluelinea SA
PAR:ALBLU
|
9.1m EUR | 0.9 | -12 | 10.8 | -18.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
187.8B USD | 4.2 | 28.8 | 16.5 | 22.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170.2B USD | 16.9 | 59.6 | 45.2 | 55.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
129B USD | 5.1 | 39.7 | 20.3 | 24.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.1B USD | 3.2 | 24.3 | 13.4 | 19.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
101.7B USD | 5.1 | 35.1 | 20.6 | 27.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.8B EUR | 1.9 | 20.7 | 11.5 | 16.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.1B USD | 8.1 | 45.8 | 25.2 | 27.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.5B USD | 10.6 | 43 | 30.6 | 33.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.5B USD | 2.1 | 25.9 | 10.2 | 17.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.9B USD | 6.3 | 22.8 | 16 | 17.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
